Hope Funds For Cancer Research

MISSION: The mission of the Hope Funds for Cancer Research is to encourage investigation of innovative cancer treatment and detection for the most difficult-to-treat and understudied cancers. The Hope Funds for Cancer Research supports scientific and medical research programs aimed at increasing knowledge relating to both cancer care and prevention. We support programs we believe have the highest probability of success in addressing unmet medical needs, which we will determine by rigorous scientific and economic analysis. SCIENTIFIC ADVISORY COUNCIL: Kenneth C. Anderson, MD; Imre Bartos, Ph.D; Lewis Cantley, PhD; William Cho, PhD; Don Cleveland, PhD; George Demetri, MD; Gina DeNicola, PhD; Wolfram Goessling, MD, PhD; William C. Hahn, MD, PhD; Kyle Hoehn, PhD; Robert Johnson, MD PhD; Carla Kim PhD; Bluma Lesch, MD, PhD; Scott Power PhD; John Quackenbush, PhD; Joshua Rabinowitz, MD, PhD; Thomas Reynolds, MD; Joan M. Robbins, PhD; Taksiha Shimokawa, PhD; Frank J. Slack, PhD, Joan A. Steitz, PhD; Sohail Tavazoie, PhD; James Watson, PhD; Robert A. Weinberg PhD; Professor Bryan R.G. Williams, PhD; Monte Winslow, PhD; Richard Young, PhD. BOARD OF TRUSTEES: Leah Rush Cann, Lewis C. Cantley, Ph.D., Katherine Dean, Samuel Gillson, Dan Gold, PhD, Jessica Guertin, Elizabeth Griffin, Adrian Hobden, PhD, Charles Holmes, Eugene Kennedy, MD, Bluma Lesch, MD, PhD, Robert Johnson, MD, PhD, Malcolm A.S. Moore, DPhil, Andrew Mullen, PhD, Steven A. Navarro, JD, John E. Parks, Andrew Robertson, David J. Straus, MD, J. Gregory Van Schaack, John Archer Wells, Bryan R.G. Williams; Life Trustees: Robert Bazell, Patricia F. Bilden, MD, Antonio J. Grillo-Lopez, MD, Gary Jobson, Jonathan Lewis, MD, PhD, Paul D. Maxwell, O. Lee Tawes III